在急性心力衰竭中联合利尿治疗:来自RICA-2注册表的见解
J Casado1, D Abad1, G Ropero-Luis2
1Servicio de Medicina Interna, Hospital Universitario de Getafe, Getafe, Madrid, Spain; Departamento de Medicina, Salud y Deportes, Facultad de Medicina, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain.
Revista clinica espanola
|January 11, 2026
概括
单独静脉注射的罗西米德是急性心力衰竭 (AHF) 患者的主要利尿策略. 结合性利尿疗法用于更生病的患者,具有更多的并发症和拥堵.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性心力衰竭 (AHF) 是住院的主要原因.
- 利尿疗法是管理AHF的基石.
- 了解当前的利尿剂策略和患者个人资料对于优化AHF护理至关重要.
研究的目的:
- 描述住院AHF患者使用的利尿策略.
- 为了确定与不同的利尿剂方案相关的临床特征.
主要方法:
- 在RICA-2注册表中对588名AHF患者进行多中心观察研究.
- 患者被分为三个组:单独静脉注射富罗西米德,富罗西米德加提亚齐德尿剂 (TD),或富罗西米德加乙胺 (ACZ).
主要成果:
- 在78%的患者中,单独使用静脉注射的富洛塞米德.
- 组合利尿疗法 (TD或ACZ) 在22%的患者中使用.
- 组合疗法患者在住院期间有更多的并发症,更差的功能类,更高的拥堵标志物和更大的体重减轻.
结论:
- 住院的AHF患者的主要利尿策略是静脉注射富洛塞米德单疗法.
- 结合性利尿疗法只适用于具有较高并发症和血压负担的患者.
相关概念视频
Heart Failure Drugs: Diuretics
788
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
788
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
Heart Failure VI: Adjunct Therapies
245
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
245
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Heart Failure III: Clinical Manifestations
462
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
462


